| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |